加拿大不列颠哥伦比亚省乳腺癌幸存者骨密度检测的利用情况
该回顾性人群数据关联研究分析了加拿大不列颠哥伦比亚省65岁及以上、生存≥3年的女性乳腺癌幸存者骨密度检测利用情况。1995-2008年检测比例从1.0%升至10.1%,2006-2008年检测率为26.5%。较低社会经济地位和农村居住与较低检测率相关。
要点
- 1995-2008年乳腺癌幸存者骨密度检测比例从1.0%升至10.1%,2006-2008年检测率为26.5%。
- 较低社会经济地位与农村居住者检测率更低,呈剂量依赖关系(趋势P<0.01)。
- 作者建议尤其低社会经济地位或农村居住的女性乳腺癌幸存者应按加拿大指南接受骨密度检测。
核心结论
- 加拿大不列颠哥伦比亚省乳腺癌幸存者骨密度检测利用率低,较低社会经济地位和农村居住与较低检测率相关。
研究设计与样本
- 回顾性人群数据关联研究,纳入7625名65岁及以上、生存≥3年的女性乳腺癌幸存者,分析1995-2008年骨密度检测趋势及2006-2008年相关因素。
主要发现
- 有≥1次骨密度检测的幸存者比例从1995年1.0%升至2008年10.1%,2006-2008年检测率为26.5%。
- 较低社会经济地位者PRadj=0.66-0.78,农村居住者PRadj=0.70,相比最高社会经济地位或城市居住者检测可能性低20-30%。
- 75岁及以上PRadj=0.47(95%CI 0.42,0.52),养老院居住PRadj=0.05(95%CI 0.01,0.39),近期骨质疏松性骨折PRadj=0.21(95%CI 0.14,0.32),无既往骨密度检测PRadj=0.26(95%CI 0.23,0.29)。
关键数值与推荐
- 社会经济地位和城乡居住与骨密度检测率呈剂量依赖关系(趋势P<0.01)。
临床怎么用
- 作者认为,女性乳腺癌幸存者,尤其是较低社会经济地位或农村居住者,应按加拿大指南推荐接受骨密度检测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Breast cancer survivors are at high osteoporosis risk. Bone mineral density testing plays a key role in osteoporosis management. We analyzed a historical utilization of bone mineral density testing in breast cancer survivors. The utilization remained low in the 1995-2008 period. Lower socio-economic status and rural residency were associated with lower utilization. INTRODUCTION: To evaluate the utilization of bone mineral density (BMD) testing for female breast cancer survivors aged 65+ surviving ≥ 3 years in British Columbia, Canada. METHODS: A retrospecitve population-based data linkage study. Trends in proportion of survivors with ≥ 1 BMD test for each calendar year from 1995 to 2008 were evaluated with a serial cross-sectional analysis. Associations between factors (socio-demographic and clinical) and BMD testing rates over the period 2006-2008 for 7625 survivors were evaluated with a cross-sectional analysis and estimated as adjusted prevalence ratios (PRadj) using log-binomial models. RESULTS: Proportions of survivors with ≥ 1 BMD test increased from 1.0% in 1995 to 10.1% in 2008. The BMD testing rate in 2006-2008 was 26.5%. Socio-economic status (SES) and urban/rural residence were associated with BMD testing rates in a dose-dependent relationship (p for trend< 0.01). Survivors with lower SES (PRadj = 0.66-0.78) or rural residence (PRadj = 0.70) were 20-30% less likely to have BMD tests, compared with survivors with the highest SES or urban residence. BMD testing rates were also negatively associated with older age (75+) (PRadj = 0.47; 95% CI = 0.42, 0.52), nursing home residency (0.05; 0.01, 0.39), recent osteoporotic fractures (0.21; 0.14, 0.32), and no previous BMD tests (0.26; 0.23, 0.29). CONCLUSION: Utilization of BMD testing was low for breast cancer survivors in BC, Canada. Lower SES and rural residence were associated with lower BMD testing rates. IMPLICATION FOR CANCER SURVIVORS: Female breast cancer survivors, especially those with lower SES or rural residence, should be encouraged to receive BMD tests as recommended by Canadian guidelines.
引用
- Tseng OL, Dawes MG, Spinelli JJ, et al. Utilization of bone mineral density testing among breast cancer survivors in British Columbia, Canada. Osteoporos Int. 2017. PMID: 28993862. doi:10.1007/s00198-017-4218-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。